TCL Archive Merck Serono Cancels Tecemotide Program In NSCLC, Including Two Phase III Trials September 26, 2014
TCL Archive The Clinical Trials Working Group: NCI panel considers plan to centralize clinical trial review and prioritization. NCI director faults system for duplication, “equivocal results.” August 13, 2004
TCL Archive Lame Duck NCI Director: Cancer Centers Should Run Cancer Clinical Trials System June 25, 2010
